会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 32. 发明授权
    • Apple peel powder, methods of making, and uses thereof
    • 苹果皮粉,制作方法及其用途
    • US08551554B2
    • 2013-10-08
    • US11018833
    • 2004-12-20
    • Rui Hai Liu
    • Rui Hai Liu
    • A23B7/00
    • A23G3/48A23B7/02A23G9/42A23L19/01A23L19/07A23L33/105A23L33/11A23L33/15A61K36/73A61K45/06
    • The present invention relates to a method of making a powder from apple peel by providing an apple peel, subjecting the apple peel to a phytochemical preservation treatment, drying the treated apple peel, and grinding the dried, treated apple peel to a powder. A powder from apple peel having a phenolic content and a flavonoid content similar to fresh apple peel on a fresh weight basis, where the powder has a water activity of less than 0.30 is also disclosed. The present invention also relates to a method of treating cancer in a patient by administering a powder from apple peel to a patient under conditions effective to treat cancer. Also disclosed is a method of inhibiting proliferation of cancer cells by contacting cancer cells with a powder from apple peel under conditions effective to inhibit proliferation of the cancer cells.
    • 本发明涉及一种通过提供苹果皮,通过苹果皮进行植物化学保存处理,干燥处理的苹果皮以及将经干燥处理的苹果皮研磨成粉末的苹果皮来制造粉末的方法。 还公开了具有酚含量的苹果皮的粉末和类似于新鲜苹果皮的类黄酮含量,其中粉末的水分活度小于0.30。 本发明还涉及通过在有效治疗癌症的条件下向患者施用苹果皮中的粉末来治疗患者的癌症的方法。 还公开了通过在有效抑制癌细胞增殖的条件下将癌细胞与来自苹果皮的粉末接触来抑制癌细胞增殖的方法。
    • 40. 发明授权
    • Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
    • 使用少突胶质细胞祖细胞的先天性去神经系膜前纤的髓鞘形成
    • US08206699B2
    • 2012-06-26
    • US12111839
    • 2008-04-29
    • Steven A. GoldmanNeeta Singh RoyMartha Windrem
    • Steven A. GoldmanNeeta Singh RoyMartha Windrem
    • A01N63/00A01N65/00
    • C12N5/0623A61K35/12A61K35/30C12N5/0618C12N5/0619C12N5/0622C12N2510/00G01N33/5005G01N33/56966Y02A50/467
    • One form of the present invention is directed to a method of remyelinating demyelinated axons by treating the demyelinated axons with oligodendrocyte progenitor cells under conditions which permit remyelination of the axons. Another aspect of the present invention relates to a method of treating a subject having a condition mediated by a loss of myelin or a loss of oligodendrocytes by administering to the subject oligodendrocyte progenitor cells under conditions effective to treat the condition mediated by a loss of myelin or a loss of oligodendrocytes. A further aspect of the present invention relates to an in vitro method of identifying and separating oligodendrocyte progenitor cells from a mixed population containing other mammalian brain or spinal cord cell types. This further aspect of the present invention involves removing neurons and neuronal progenitor cells from the mixed population to produce a treated mixed population. Oligodendrocyte progenitor cells are then separated from the treated mixed population to form an enriched population of oligodendrocyte progenitor cells.
    • 本发明的一种形式涉及通过在允许轴突再髓鞘化的条件下用少突胶质祖细胞处理脱髓鞘化的轴突来再髓鞘化轴突再髓鞘的方法。 本发明的另一方面涉及一种通过在有效治疗由髓磷脂损失介导的病症治疗的条件下向受试者少突胶质祖细胞施用治疗具有由髓磷脂损失或少突胶质细胞损失介导的病症的受试者的方法,或 少突胶质细胞的丧失。 本发明的另一方面涉及从含有其它哺乳动物脑或脊髓细胞类型的混合群体中鉴定和分离少突胶质祖细胞祖细胞的体外方法。 本发明的另一方面涉及从混合群体中去除神经元和神经元祖细胞以产生经处理的混合群体。 然后从处理的混合群体中分离少突胶质细胞祖细胞以形成少突胶质细胞祖细胞的富集群体。